Headlines about Vical (NASDAQ:VICL) have trended somewhat positive recently, Accern Sentiment reports. Accern scores the sentiment of news coverage by analyzing more than 20 million blog and news sources. Accern ranks coverage of companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Vical earned a daily sentiment score of 0.16 on Accern’s scale. Accern also assigned news coverage about the biotechnology company an impact score of 46.9414917292975 out of 100, indicating that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
Vical (NASDAQ:VICL) traded up 1.25% during trading on Friday, reaching $2.43. 28,088 shares of the company’s stock traded hands. Vical has a one year low of $2.05 and a one year high of $4.33. The company has a 50 day moving average of $2.59 and a 200 day moving average of $2.35. The firm’s market cap is $27.71 million.
Vical (NASDAQ:VICL) last posted its quarterly earnings results on Tuesday, August 8th. The biotechnology company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.28) by $0.02. The business had revenue of $3.42 million during the quarter, compared to analyst estimates of $3.35 million. Vical had a negative net margin of 92.02% and a negative return on equity of 26.09%. Equities research analysts predict that Vical will post ($1.05) EPS for the current year.
VICL has been the topic of a number of recent research reports. HC Wainwright set a $9.00 target price on shares of Vical and gave the stock a “buy” rating in a research report on Monday, June 12th. Rodman & Renshaw reiterated a “buy” rating and issued a $9.00 price target on shares of Vical in a research note on Monday, June 12th. Finally, Ifs Securities reiterated an “outperform” rating on shares of Vical in a research note on Tuesday, August 8th.
WARNING: This article was originally reported by Rincon Hill News and is owned by of Rincon Hill News. If you are accessing this article on another publication, it was illegally copied and republished in violation of US & international copyright & trademark law. The original version of this article can be viewed at https://rinconhillneighbors.org/2017/08/19/vical-nasdaqvicl-getting-somewhat-positive-press-coverage-analysis-shows-updated.html.
Receive News & Ratings for Vical Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vical Incorporated and related companies with our FREE daily email newsletter.